Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials!!

Clinical Trial 16705


Study Summary:

Study 16707 Flyer
Click image to enlarge

You may qualify for a clinical research study to test the effectiveness of a new investigational drug for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL).

Diffuse large B-cell lymphoma is a type of non-Hodgkin’s lymphoma, and is relatively common.

Qualifications Include:

  • Adults ages 18 and older
  • Histologically confirmed aggressive B-cell DLBCL
  • Not currently undergoing chemotherapy, radiotherapy, immunotherapy, biologic, investigational, or hormonal therapy for the treatment of lymphoma
  • Prior unsuccessful treatment with targeted anti-CD20-based therapy combined with chemotherapy. ‘Unsuccessful’ meaning a return of the cancer or lack of response to the treatments.

Participants who qualify for this study may receive all study related care and study drug at no cost.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.